Browse By

Tag Archives: medical

James E. Wagner Cultivation Reaches Supply Agreement with OCS and Prepares to Launch Products into Recreational Market

KITCHENER, Ontario, Feb. 19, 2020 (GLOBE NEWSWIRE) — James E. Wagner Cultivation Corporation (“JWC” or the “Corporation”) (TSX: JWCA.V; OTCQX: JWCAF), has entered into a Master Cannabis Supply Agreement effective February 6, 2020, with the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). This

WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada

New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations TORONTO, Feb. 13, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that

Curaleaf Announces Expiration of HSR Waiting Period for Proposed Acquisition of Grassroots

WAKEFIELD, Mass., Feb. 13, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”), a leading vertically integrated cannabis operator in the United States, today announced the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) has expired with respect to the acquisition of GR Companies, Inc.

Khiron to Host Investor Webcast Live on February 11, 2020

Khiron invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations TORONTO, Feb. 10, 2020 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is

WeedMD Subsidiary Starseed Medicinal Signs Innovative Benefits Provider myHSA to Medical Cannabis Program

Starseed and WeedMD become preferred medical cannabis suppliers to over 51,000 myHSA clients across Canada TORONTO, Feb. 10, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that its subsidiary Starseed Medicinal Inc.